Just as you are able to sit down for the first time in hours in the ED, a colleague walks by and says, “I don’t know what’s going on with your new patient, but she doesn’t look good.” You hurry to find a frail, elderly woman sitting upright, mouth agape. She is tachypneic, with a respiratory rate of 40 breaths/min, and is using accessory respiratory muscles. According to EMS, her pulse oximetry reading improved from 67% on 2-L nasal cannula to 80% on a 15-L nonrebreather mask. She has virtually no breath sounds on lung auscultation except for occasional faint wheezing. You initiate bilevel noninvasive ventilation (NIV), and inline continuous nebulizer treatments are started. The respiratory therapist suggests endotracheal intubation, and you suspect that extubation in the ICU will be difficult, further along the treatment course. As the respiratory therapist sets the bilevel NIV at a PIP 12 over PEEP 5, she asks you, “What parameters would make you decide to proceed with endotracheal intubation?”
Meanwhile, you are alerted to an EMS arrival in the resuscitation bay. They have brought an obese 60-something-year-old man, who was “found down.” Initial evaluation was remarkable for somnolence with arousal to painful stimuli. He has been unable to provide his name or past medical history. His vital signs are remarkable for a respiratory rate of 10 breaths/min and hypoxia with a SpO2 in the mid-80s on room air. He has right lower lung basilar crackles. According to EMS, his hypoxia did not improve on a nonrebreather mask, so CPAP was initiated in the field. Since then, his SpO2 has improved marginally to the high 80s, but he still arouses only to painful stimuli. During your initial assessment, the patient vomits into the NIV mask, aspirates, and his SpO2 plummets when the face mask is removed. As you scramble to assemble RSI and intubation materials, you wonder if CPAP was contraindicated and if this airway catastrophe could have been prevented.
Mulling over your stressful patient load, you walk to the bedside of a 9-year-old girl with a past medical history of cerebral palsy. Although she is only minimally interactive, she is accompanied by her attentive parents who are deeply involved with her medical care. Her mother looks worried and explains that her daughter “isn’t breathing right” and that she feels warm. The father mentions a history of a worsening cough. On chart review, you note that her restrictive lung disease from underlying cerebral palsy is worsening, and that she now requires BPAP at night. On examination, you see a mentally and developmentally delayed girl with subcostal retractions, tachycardia to 125 beats/min, tachypnea to 35 breaths/min, and an oral temperature of 38.3°C (101°F), but she is maintaining an oxygen saturation of 97% on room air. A chest x-ray confirms a right upper lobar pneumonia. The patient shows increased work of breathing, and you wonder if NIV would help.
Acute respiratory failure is an emergency that requires a management strategy tailored to the individual patient and to the resources available. Endotracheal intubation is definitive airway management, but it can have complications. In addition, rapid sequence intubation (RSI) requires a degree of preparation and time that might not be available in the acutely distressed patient. For example, important equipment needs assembly, often the clinical environment is not optimal (such as with refractory hypoxia or abnormal anatomy that makes RSI riskier), or the patient has an underlying condition that could lead to further complication as a result of paralysis (such as in acidosis). Ultimately, with RSI there is a level of risk to the patient, both during the initial procedure of induction, sedation, laryngoscopy, and tube delivery, as well as post procedure, with ventilator-associated risks such as pulmonary barotrauma or ventilator-associated pneumonia.
In consideration of risks associated with definitive airway management, noninvasive strategies that include continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BPAP) are viable management options. These techniques provide a “fast-on” intervention that provides more respiratory support than nasal cannula or a conventional face mask. Unlike endotracheal intubation, NIV is not definitive airway management, and the patient must be closely monitored for signs of clinical deterioration. Nonetheless, NIV can improve the patient’s condition sufficiently to either reverse the underlying acute illness or, alternatively, it may serve to safely delay intubation until proper setup is available.1 In the case of patients who have a “do not intubate” (DNI) directive, NIV may also allow for temporary life-sustaining support while a potentially reversible process is addressed.2
NIV was introduced for management of acute respiratory failure in the 1940s, but became a mainstay of respiratory management only in the last 20 years. A multicenter database review over a 15-year study period from 1997 to 2011 showed that first-line NIV use increased from 29% to 42%, and the success rate improved from 69% to 84%.3 Success was defined as not requiring use of mechanical ventilation and increased patient survival.
A comprehensive understanding of the physiologic benefits of NIV can lead to efficient and clinically appropriate management decisions. As there was an excellent review article by Torres and Radeos published in a 2011 issue of EM Critical Care,4 this review is designed to provide an update of the literature since then, and to offer evolving perspectives on the increasing utilization of NIV in the setting of acute respiratory distress.
Searches were conducted through PubMed and OVID Medline® for literature from 2010 to 2016. Keywords included noninvasive ventilation, with and without the qualifying inclusion of the term acute respiratory failure, to limit the resources to acute conditions. The search was restricted to studies available in the English language. The references from the articles identified were then searched for additional references, retrieving more than 700 articles. Priority was given to articles addressing commonly occurring emergent medical conditions, with additional special attention given to topics falling under the category of emerging areas of research.
Evidence-based medicine requires a critical appraisal of the literature based upon study methodology and number of subjects. Not all references are equally robust. The findings of a large, prospective, randomized, and blinded trial should carry more weight than a case report.
To help the reader judge the strength of each reference, pertinent information about the study is included in bold type following the reference, where available. The most informative references cited in this paper, as determined by the authors, are noted by an asterisk (*) next to the number of the reference.
To continue reading, please log in or purchase access.
Nikita Joshi, MD; Molly K. Estes, MD; Kayla Shipley, MD; Hyun-Chul Danny Lee, MD
February 1, 2017
February 29, 2020
CME Objectives
Upon competion of this article, you should be able to:
Physician CME Information
Date of Original Release: February 1, 2017. Date of most recent review: January 10, 2017. Termination date: February 1, 2020.
Accreditation: EB Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the ACCME.
Credit Designation: EB Medicine designates this enduring material for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ACEP Accreditation: Emergency Medicine Practice is approved by the American College of Emergency Physicians for 48 hours of ACEP Category I credit per annual subscription.
AAFP Accreditation: This Medical Journal activity, Emergency Medicine Practice, has been reviewed and is acceptable for up to 48 Prescribed credits by the American Academy of Family Physicians per year. AAFP accreditation begins July 1, 2016. Term of approval is for one year from this date. Each issue is approved for 4 Prescribed credits. Credit may be claimed for one year from the date of each issue. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AOA Accreditation: Emergency Medicine Practice is eligible for up to 48 American Osteopathic Association Category 2-A or 2-B credit hours per year.
Needs Assessment: The need for this educational activity was determined by a survey of medical staff, including the editorial board of this publication; review of morbidity and mortality data from the CDC, AHA, NCHS, and ACEP; and evaluation of prior activities for emergency physicians.
Target Audience: This enduring material is designed for emergency medicine physicians, physician assistants, nurse practitioners, and residents.
Goals: Upon completion of this activity, you should be able to: (1) demonstrate medical decision-making based on the strongest clinical evidence; (2) cost-effectively diagnose and treat the most critical presentations; and (3) describe the most common medicolegal pitfalls for each topic covered.
Discussion of Investigational Information: As part of the journal, faculty may be presenting investigational information about pharmaceutical products that is outside Food and Drug Administration–approved labeling. Information presented as part of this activity is intended solely as continuing medical education and is not intended to promote off-label use of any pharmaceutical product.
Faculty Disclosure: It is the policy of EB Medicine to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-sponsored educational activities. All faculty participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. In compliance with all ACCME Essentials, Standards, and Guidelines, all faculty for this CME activity were asked to complete a full disclosure statement. The information received is as follows: Dr. Joshi, Dr. Estes, Dr. Shipley, Dr. Lee, Dr. Litell, Dr. Walsh, Dr. Damilini, Dr. Toscano, Dr. Jagoda, and their related parties report no significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) discussed in this educational presentation.
Commercial Support: This issue of Emergency Medicine Practice did not receive any commercial support.
Earning Credit: Two Convenient Methods: (1) Go online to www.ebmedicine.net/CME and click on the title of the article. (2) Mail or fax the CME Answer And Evaluation Form (included with your June and December issues) to EB Medicine.
Hardware/Software Requirements: You will need a Macintosh or PC to access the online archived articles and CME testing.
Additional Policies: For additional policies, including our statement of conflict of interest, source of funding, statement of informed consent, and statement of human and animal rights, visit www.ebmedicine.net/policies.
Emergency Management Of Dyspnea In Dying Patients (FREE) - Emergency Medicine Practice - May 2013
Emergency Ultrasound In Patients With Respiratory Distress (FREE) - EM Critical Care - February 2012